Srividhya Venkatesan
Research Associate-1
Research & Publications
Biography
Coauthors
Selected Publications
- PD-1 maintains CD8 T cell tolerance towards cutaneous neoantigensDamo M, Hornick N, Venkat A, William I, Clulo K, Venkatesan S, He J, Fagerberg E, Loza J, Kwok D, Tal A, Buck J, Cui C, Singh J, Damsky W, Leventhal J, Krishnaswamy S, Joshi N. PD-1 maintains CD8 T cell tolerance towards cutaneous neoantigens. Nature 2023, 619: 151-159. PMID: 37344588, DOI: 10.1038/s41586-023-06217-y.
- An In Vivo Model for Elucidating the Role of an Erythroid-Specific Isoform of Nuclear Export Protein Exportin 7 (Xpo7) in Murine ErythropoiesisModepalli S, Martinez-Morilla S, Venkatesan S, Fasano J, Paulsen K, Görlich D, Hattangadi S, Kupfer G. An In Vivo Model for Elucidating the Role of an Erythroid-Specific Isoform of Nuclear Export Protein Exportin 7 (Xpo7) in Murine Erythropoiesis. Experimental Hematology 2022, 114: 22-32. PMID: 35973480, PMCID: PMC10165728, DOI: 10.1016/j.exphem.2022.08.001.
- Roles of Bone Morphogenetic Protein Receptor 1A in Germinal Centers and Long-Lived Humoral ImmunityTomayko MM, Karaaslan S, Lainez B, Conter LJ, Song E, Venkatesan S, Mishina Y, Shlomchik MJ. Roles of Bone Morphogenetic Protein Receptor 1A in Germinal Centers and Long-Lived Humoral Immunity. ImmunoHorizons 2021, 5: 284-297. PMID: 33975878, DOI: 10.4049/immunohorizons.2100019.
- miR-181a regulates erythroid enucleation via the regulation of Xpo7 expressionFigueroa A, Fasano JD, Martinez-Morilla S, Venkatesan S, Kupfer G, Hattangadi SM. miR-181a regulates erythroid enucleation via the regulation of Xpo7 expression. Haematologica 2018, 103: e341-e344. PMID: 29567782, PMCID: PMC6068031, DOI: 10.3324/haematol.2017.171785.
- Erythroid-Specific Variant of the Nuclear Exportin Xpo7 Conserved Only in Mammals May Explain Functional Differences Between Mammalian Definitive and Lower Vertebrate (or Primitive) ErythropoiesisMartinez-Morilla S, Venkatesan S, Katharina S, Cooney J, Paw B, Gorlich D, Hattangadi S. Erythroid-Specific Variant of the Nuclear Exportin Xpo7 Conserved Only in Mammals May Explain Functional Differences Between Mammalian Definitive and Lower Vertebrate (or Primitive) Erythropoiesis. Blood 2016, 128: 2440. DOI: 10.1182/blood.v128.22.2440.2440.
- Mmu-Mir-181a Regulates Terminal Erythroid Nuclear Maturation By Regulating Levels of Xpo7Figueroa A, Martinez-Morilla S, Venkatesan S, Hattangadi S. Mmu-Mir-181a Regulates Terminal Erythroid Nuclear Maturation By Regulating Levels of Xpo7. Blood 2014, 124: 2669. DOI: 10.1182/blood.v124.21.2669.2669.
- Histones to the cytosol: exportin 7 is essential for normal terminal erythroid nuclear maturationHattangadi SM, Martinez-Morilla S, Patterson HC, Shi J, Burke K, Avila-Figueroa A, Venkatesan S, Wang J, Paulsen K, Görlich D, Murata-Hori M, Lodish HF. Histones to the cytosol: exportin 7 is essential for normal terminal erythroid nuclear maturation. Blood 2014, 124: 1931-1940. PMID: 25092175, PMCID: PMC4168348, DOI: 10.1182/blood-2013-11-537761.
- Histones To The Cytosol: Role Of Nuclear Protein Export In Erythroid Nuclear CondensationFigueroa A, Venkatesan S, Hattangadi S. Histones To The Cytosol: Role Of Nuclear Protein Export In Erythroid Nuclear Condensation. Blood 2013, 122: 310. DOI: 10.1182/blood.v122.21.310.310.
- Graft-Versus-Host-Disease Recruits Both Monocyte and Pre-Conventional Dendritic Cell-Derived Tissue Antigen Presenting Cells Independent Of CCR2 and CCR6Morin-Zorman S, Wysocki C, Matte-Martone C, Juchem K, Tan H, Venkatesan S, Rothstein D, Lakkis F, Shlomchik W. Graft-Versus-Host-Disease Recruits Both Monocyte and Pre-Conventional Dendritic Cell-Derived Tissue Antigen Presenting Cells Independent Of CCR2 and CCR6. Blood 2013, 122: 4463. DOI: 10.1182/blood.v122.21.4463.4463.
- Memory T cells from minor histocompatibility antigen–vaccinated and virus-immune donors improve GVL and immune reconstitutionLi N, Matte-Martone C, Zheng H, Cui W, Venkatesan S, Tan HS, McNiff J, Demetris AJ, Roopenian D, Kaech S, Shlomchik WD. Memory T cells from minor histocompatibility antigen–vaccinated and virus-immune donors improve GVL and immune reconstitution. Blood 2011, 118: 5965-5976. PMID: 21917752, PMCID: PMC3228506, DOI: 10.1182/blood-2011-07-367011.
- Graft-versus-Leukemia (GVL) against Mouse Blast-Crisis Chronic Myelogenous Leukemia (BC-CML) and Chronic-Phase Chronic Myelogenous Leukemia (CP-CML): Shared Mechanisms of T Cell Killing, but Programmed Death Ligands Render CP-CML and Not BC-CML GVL ResistantMatte-Martone C, Venkatesan S, Tan HS, Athanasiadis I, Chang J, Pavisic J, Shlomchik WD. Graft-versus-Leukemia (GVL) against Mouse Blast-Crisis Chronic Myelogenous Leukemia (BC-CML) and Chronic-Phase Chronic Myelogenous Leukemia (CP-CML): Shared Mechanisms of T Cell Killing, but Programmed Death Ligands Render CP-CML and Not BC-CML GVL Resistant. The Journal Of Immunology 2011, 187: 1653-1663. PMID: 21768400, PMCID: PMC3150287, DOI: 10.4049/jimmunol.1100311.
- Graft-versus-Host Disease Is Independent of Innate Signaling Pathways Triggered by Pathogens in Host Hematopoietic CellsLi H, Matte-Martone C, Tan HS, Venkatesan S, McNiff J, Demetris AJ, Jain D, Lakkis F, Rothstein D, Shlomchik WD. Graft-versus-Host Disease Is Independent of Innate Signaling Pathways Triggered by Pathogens in Host Hematopoietic Cells. The Journal Of Immunology 2011, 186: 230-241. PMID: 21098219, PMCID: PMC5822434, DOI: 10.4049/jimmunol.1002965.
- Langerhans cells are not required for graft-versus-host diseaseLi H, Kaplan DH, Matte-Martone C, Tan HS, Venkatesan S, Johnson K, Demetris AJ, McNiff J, Shlomchik MJ, Shlomchik WD. Langerhans cells are not required for graft-versus-host disease. Blood 2010, 117: 697-707. PMID: 20944073, PMCID: PMC3031488, DOI: 10.1182/blood-2010-07-299073.
- Memory CD8. + T Cells Specific for Minor Histocompatibility Antigen H60 Can Mediate the Graft-Versus-Leukemia Effect.Li N, Matte-Martone C, Venkatesan S, Shlomchik W. Memory CD8. + T Cells Specific for Minor Histocompatibility Antigen H60 Can Mediate the Graft-Versus-Leukemia Effect. Blood 2009, 114: 1332. DOI: 10.1182/blood.v114.22.1332.1332.
- CD8+ Central Memory T Cells Mediate Graft-Versus-Host Disease Although Retain Graft-Versus-Leukemia Effect.Zheng H, Matte C, Anderson B, Venkatesan S, Jain D, Shlomchik M, Shlomchik W. CD8+ Central Memory T Cells Mediate Graft-Versus-Host Disease Although Retain Graft-Versus-Leukemia Effect. Blood 2005, 106: 1312. DOI: 10.1182/blood.v106.11.1312.1312.
- CD4+ Effector Memory and Naive T Cells Mediate Graft-Versus-Leukemia Via Direct Recognition of MHCII on Leukemic Cells.Zheng H, Matte C, Venkatesan S, Anderson B, Shlomchik M, Shlomchik W. CD4+ Effector Memory and Naive T Cells Mediate Graft-Versus-Leukemia Via Direct Recognition of MHCII on Leukemic Cells. Blood 2005, 106: 579. DOI: 10.1182/blood.v106.11.579.579.